Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-22

Clinical Trial Update: Vitamin D for the Prevention of Diabetes Type 2 [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial tested whether Vitamin D supplementation can prevent type 2 diabetes in people with impaired glucose tolerance. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: University of Tromso | Conditions: Impaired Glucose Tolerance | Phase 2, Phase 3 | Status: COMPLETED